Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Oct
2
2023
COP28 UAE Presidency Announces Water Agenda Cadwalader, Wickersham & Taft LLP
Oct
2
2023
Farm Bill Extended – for Now Bradley Arant Boult Cummings LLP
Oct
2
2023
FDA Addresses Antibiotics in Animal Feed in New Draft Guidance Document Keller and Heckman LLP
Oct
2
2023
U.S. Executive Branch Update – October 2, 2023 Squire Patton Boggs (US) LLP
Oct
2
2023
FDA Proposes New Rule to Regulate Laboratory Developed Tests Nelson Mullins
Sep
30
2023
FDA Will Hold 2023 NanoDay Symposium on Continuous Manufacturing of Nanomaterials Bergeson & Campbell, P.C.
Sep
29
2023
Weight-Loss Programs in Florida: State Law Considerations for GLP-1 Telehealth Providers McDermott Will & Emery
Sep
29
2023
GAO Releases Report on Detecting, Limiting Exposure to, and Treating PFAS Contamination Bergeson & Campbell, P.C.
Sep
29
2023
FDA’s Updated HARPC Draft Guidance Addresses Concerns Regarding Industry Approach to Sesame Keller and Heckman LLP
Sep
28
2023
Maritime Transportation: Whose Responsibility Is It When Produce Arrives in Damaged Condition? Blank Rome LLP
Sep
28
2023
A Second Chance to Win Your Government Healthcare Contract Sheppard, Mullin, Richter & Hampton LLP
Sep
28
2023
Trending in Telehealth: September 19 – 25, 2023 McDermott Will & Emery
Sep
28
2023
Diagnosing Health Care Podcast – Episode 70: Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs [Podcast] Epstein Becker & Green, P.C.
Sep
28
2023
What’s Kühler Than Kühl? No Likelihood of Confusion McDermott Will & Emery
Sep
28
2023
Grubhub Relishes Victory Against Trademark Preliminary Injunction McDermott Will & Emery
Sep
28
2023
SEC Staff Comment Asks Company for Quantitative Disclosure Related to Menu Price Impacts on Revenue Barnes & Thornburg LLP
Sep
28
2023
Pre-Enforcement Commercialization Isn’t “Impossible” Basis for Personal Jurisdiction of Nonresident Defendant McDermott Will & Emery
Sep
28
2023
Impending Rite Aid Chapter 11 Bankruptcy – 4 Things Trade Creditors and Landlords Should Know Stark & Stark
Sep
28
2023
That Was Fast: Judge Orders Cannabis Company to Recognize and Bargain with Union Under “Cemex" Proskauer Rose LLP
Sep
27
2023
Overview of Recent Anti-Corruption Enforcement Actions in the Pharmaceutical Industry in China Sheppard, Mullin, Richter & Hampton LLP
Sep
27
2023
FDA Publishes Two New Chapters of Human Foods HARPC Draft Guidance Keller and Heckman LLP
Sep
26
2023
USCIS Removes Biometric Services Fee for Form I-539 Greenberg Traurig, LLP
Sep
26
2023
Updates on China’s Regulation of Food Ingredients and Additives Keller and Heckman LLP
Sep
26
2023
FDA Responds to CFP Recommendations for Food Code Update Keller and Heckman LLP
Sep
26
2023
In Starch Contrast: Australian Patent Office Makes Key Finding on Use of Trade Marks in Patent Specifications K&L Gates
Sep
25
2023
Kraft Recalls “Unpleasant” American Cheese Singles Keller and Heckman LLP
Sep
25
2023
Bonding Requirements Complicate TTB Permit Filing Norris McLaughlin P.A.
Sep
25
2023
Hawaii and California, Seeking to Shed Their Dreary Public Images, Liberalize Psychedelics Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins